PAPER Zamboni G, Maramotti R, Salemme S, Tondelli M, Adani G, Vinceti G, Carbone C, Filippini T, Vinceti M, Pagnoni G, Chiari A
SEARCH RESULTS
331170 RESULTS
PAPER Tian X, Zhao Y, Zhu Y, Cui M
Association between elevated blood-brain barrier permeability and the risk of progressive cognitive decline: A longitudinal study.
Arch Gerontol Geriatr. 2024 Apr 20;124:105441. PubMed: 38643666PAPER Lemche E, Killick R, Mitchell J, Caton PW, Choudhary P, Howard JK
Molecular mechanisms linking type 2 diabetes mellitus and late-onset Alzheimer's disease: A systematic review and qualitative meta-analysis.
Neurobiol Dis. 2024 Apr 19;:106485. PubMed: 38643861PAPER Cai Z, Yang Z, Li H, Fang Y
Research progress of PROTACs for neurodegenerative diseases therapy.
Bioorg Chem. 2024 Apr 18;147:107386. PubMed: 38643565PAPER Sharma V, Chander Sharma P, Reang J, Yadav V, Kumar Tonk R, Majeed J, Sharma K
Impact of GSK-3β and CK-1δ on Wnt signaling pathway in alzheimer disease: A dual target approach.
Bioorg Chem. 2024 Apr 17;147:107378. PubMed: 38643562Thomas Beach on Etiology of White Matter Hyperintensities in Autosomal Dominant and Sporadic Alzheimer Disease.
COMMENT Agree that it is no longer correct to assume that white matter rarefaction is equivalent to or completely accounted for by small vessel disease. Our comprehensive postmortem study suggests that neuofibrillary tangles are statistically a much greater predi
Thomas Beach on Skin Deep: Punch Biopsies Detect Synucleinopathies
COMMENT The publication of Gibbons et al., like most clinical biomarker studies, suffers first and foremost from the use of an inadequate gold standard. The clinical diagnoses of Parkinson’s disease, dementia with Lewy bodies, and multiple system atrophy are all
CSIRO Postdoctoral Fellowship in PET Neuroimaging for Alzheimer's Disease
JOB 2024-04-21 Employer CSIRO Principal Investigator Vincent Dore Contact For further information about the role and to apply, https://jobs.csiro.au/job-invite/95539/. Description CSIRO Early Research Career (CERC) Postdoctoral Fellowships provide opportunities to scien
PAPER
Repurposing a diabetes drug to treat Parkinson's disease.
Nat Med. 2024 Apr 20; PubMed: 38643318PAPER Koch NA, Voss P, Cisneros-Franco JM, Drouin-Picaro A, Tounkara F, Ducharme S, Guitton D, de Villers-Sidani É
Eye movement function captured via an electronic tablet informs on cognition and disease severity in Parkinson's disease.
Sci Rep. 2024 Apr 20;14(1):9082. PubMed: 38643273PAPER Stephens GS, Park J, Eagle A, You J, Silva-Pérez M, Fu CH, Choi S, Romain CP, Sugimoto C, Buffington SA, Zheng Y, Costa-Mattioli M, Liu Y, Robison AJ, Chin J
Persistent ∆FosB expression limits recurrent seizure activity and provides neuroprotection in the dentate gyrus of APP mice.
Prog Neurobiol. 2024 Apr 18;:102612. PubMed: 38642602PAPER Lai JZ, Lin CY, Chen SJ, Cheng YM, Abe M, Lin TC, Chien FC
Temporal-Focusing Multiphoton Excitation Single-Molecule Localization Microscopy Using Spontaneously Blinking Fluorophores.
Angew Chem Int Ed Engl. 2024 Apr 19;:e202404942. PubMed: 38641901PAPER McClarty BM, Rodriguez G, Dong H
Class 1 histone deacetylases differentially modulate memory and synaptic genes in a spatial and temporal manner in aged and APP/PS1 mice.
Brain Res. 2024 Apr 18;:148951. PubMed: 38642789PAPER Souza ID, Lanças FM, Hallak JE, Queiroz ME
Fiber-in-tube SPME-CapLC-MS/MS method to determine Aβ peptides in cerebrospinal fluid obtained from Alzheimer's patients.
J Chromatogr A. 2024 Apr 16;1723:464913. PubMed: 38642449PAPER Corbett A, Williams G, Creese B, Hampshire A, Palmer A, Brooker H, Ballard C
Impact of Short-Term Computerized Cognitive Training on Cognition in Older Adults With and Without Genetic Risk of Alzheimer's Disease: Outcomes From the START Randomized Controlled Trial.
J Am Med Dir Assoc. 2024 Apr 17; PubMed: 38642588Current Filters
No filters selected